TGFB1 and systemic sclerosis: For instance, Fujiwara et al. demonstrated that MFG-E8 reduces fibrosis in SSc by inhibiting TGF-β signaling, thereby decreasing collagen production and fibrotic markers, which underscores its therapeutic potential against the disease.51